NCT05553080View on ClinicalTrials.gov

Significance of Immunohistochemical Expression of Fascin-1 in Colorectal Carcinoma

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

September 30, 2022

Study Completion Date

December 1, 2022

Conditions
Cancer of Colon
Interventions
GENETIC

Immunohistochemistry

immunohistochemical staining of colorectal carcinoma specimens by anti human fascin antibody.

Trial Locations (2)

82524

Maisa Hashem Mohammed, Sohag

Sohag faculty of medicine, Sohag

All Listed Sponsors
lead

Sohag University

OTHER

NCT05553080 - Significance of Immunohistochemical Expression of Fascin-1 in Colorectal Carcinoma | Biotech Hunter | Biotech Hunter